Eur Rev Med Pharmacol Sci 2018; 22 (14): 4419-4426
DOI: 10.26355/eurrev_201807_15492

MiR-129 is involved in the occurrence of uterine fibroid through inhibiting TET1

J.-L. Lu, L. Zhao, S.-C. Han, J.-L. Bi, H.-X. Liu, C. Yue, L. Lin

Department of Gynecology and Obstetrics, The Second Hospital of Dalian Medical University, Dalian, China. bigcatlinlin@163.com


OBJECTIVE: To detect the expressions of micro ribonucleic acid (miR)-129 and its target gene in uterine fibroid tissues and to investigate the role of miR-129 in the occurrence of uterine fibroid.

PATIENTS AND METHODS: The expressions of miR-129 and its target gene ten-eleven translocation 1 (TET1) were detected via quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Dual-luciferase reporter gene and Western blotting were used to verify the regulatory relation between miR-129 and target gene. The effects of miR-129 on the proliferation, apoptosis, cycle and extracellular matrix (ECM) of uterine fibroid cells were investigated via transfection with miR-129 mimics and TET1 small-interfering RNA (siRNA).

RESULTS: MiR-129 was lowly expressed in uterine fibroid. The expression of miR-129 was regulated by sex hormones. The highly expressed miR-129 promoted apoptosis and inhibited proliferation through reducing the low expression of TET1. At the same time, miR-129 affected the accumulation of ECM.

CONCLUSIONS: The expression of miR-129 in uterine fibroid is lower, and the proliferation capacity of tumor cells is enhanced, thus promoting the occurrence and development of uterine fibroid.

Free PDF Download

To cite this article

J.-L. Lu, L. Zhao, S.-C. Han, J.-L. Bi, H.-X. Liu, C. Yue, L. Lin
MiR-129 is involved in the occurrence of uterine fibroid through inhibiting TET1

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 14
Pages: 4419-4426
DOI: 10.26355/eurrev_201807_15492